Modulation of the ETV6::RUNX1 Gene Fusion Prevalence in Newborns by Corticosteroid Use During Pregnancy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26072971 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Leticia Benítez und 16 weiteren Autor:innen. Beteiligte Einrichtung: BCNatal|Fetal Medicine Research Center, Hospital Clínic and Hospital Sant Joan de Deu, University of Barcelona, 08950 Barcelona, Spain. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 2 Subunit, Oncogene Proteins, Fusion, Proto-Oncogene Proteins c-ets, Adrenal Cortex Hormones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, la caixa, Agència de Gestió d'Ajuts Universitaris i de Recerca.
Abstract (Originalsprache)
ETV6::RUNX1-positive pediatric acute lymphoblastic leukemia frequently has a prenatal origin and follows a two-hit model: a first somatic alteration leads to the formation of the oncogenic fusion gene ETV6::RUNX1 and the generation of a preleukemic clone in utero. Secondary hits after birth are necessary to convert the preleukemic clone into clinically overt leukemia. However, prenatal factors triggering the first hit have not yet been determined. Here, we explore the influence of maternal factors during pregnancy on the prevalence of the ETV6::RUNX1 fusion. To this end, we employed a nested interventional cohort study (IMPACT-BCN trial), including 1221 pregnancies (randomized into usual care, a Mediterranean diet, or mindfulness-based stress reduction) and determined the prevalence of the fusion gene in the DNA of cord blood samples at delivery (n = 741) using the state-of-the-art GIPFEL (genomic inverse PCR for exploration of ligated breakpoints) technique. A total of 6.5% (n = 48 of 741) of healthy newborns tested positive for ETV6::RUNX1. Our multiple regression analyses showed a trend toward lower ETV6::RUNX1 prevalence in offspring of the high-adherence intervention groups. Strikingly, corticosteroid use for lung maturation during pregnancy was significantly associated with ETV6::RUNX1 (adjusted OR 3.9, 95% CI 1.6–9.8) in 39 neonates, particularly if applied before 26 weeks of gestation (OR 7.7, 95% CI 1.08–50) or if betamethasone (OR 4.0, 95% CI 1.4–11.3) was used. Prenatal exposure to corticosteroids within a critical time window may therefore increase the risk of developing ETV6::RUNX1+ preleukemic clones and potentially leukemia after birth. Taken together, this study indicates that ETV6::RUNX1 preleukemia prevalence may be modulated and potentially prevented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BCNatal|Fetal Medicine Research Center, Hospital Clínic and Hospital Sant Joan de Deu, University of Barcelona, 08950 Barcelona, Spain.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer, 08036 Barcelona, Spain.
- Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.
- German Cancer Consortium, Partner Site Essen-Düsseldorf, 40225 Düsseldorf, Germany.
- Deutsches Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.
- Red Española de Terapias Avanzadas-Instituto de Salud Carlos III (ISCII), 28029 Madrid, Spain.
ORCID-Profile: Leticia Benítez, Fàtima Crispi, Sara Castro-Barquero, Francesca Crovetto, Lina Youssef, Rosa Casas, Eduard Vieta, Ramon Estruch
Förderung
- Instituto de Salud Carlos III
- la caixa
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Universitat de Barcelona
- Centre for Biomedical Network Research on Rare Diseases
- Deutsche José-Carreras Leukämie-Stiftung
- Deutsche Forschungsgemeinschaft
- German Cancer Aid
Zitieren
APA
Benítez, L., Fischer, U., Crispi, F., Castro-Barquero, S., Crovetto, F., Larroya, M., Youssef, L., Kameri, E., Castillo, H., Bueno, C., Casas, R., Borras, R., Vieta, E., Estruch, R., Menéndez, P., Borkhardt, A., & Gratacós, E. (2025). Modulation of the ETV6::RUNX1 Gene Fusion Prevalence in Newborns by Corticosteroid Use During Pregnancy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072971
Vancouver
Benítez L, Fischer U, Crispi F, Castro-Barquero S, Crovetto F, Larroya M, et al. Modulation of the ETV6::RUNX1 Gene Fusion Prevalence in Newborns by Corticosteroid Use During Pregnancy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072971
BibTeX
@article{Bentez2025,
author = {Benítez, Leticia and Fischer, Ute and Crispi, Fàtima and Castro-Barquero, Sara and Crovetto, Francesca and Larroya, Marta and Youssef, Lina and Kameri, Ersen and Castillo, Helena and Bueno, Clara and Casas, Rosa and Borras, Roger and Vieta, Eduard and Estruch, Ramon and Menéndez, Pablo and Borkhardt, Arndt and Gratacós, Eduard},
title = {Modulation of the ETV6::RUNX1 Gene Fusion Prevalence in Newborns by Corticosteroid Use During Pregnancy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26072971}
}
EUVIMED